Testing a new epilepsy medicine for safety in healthy people and patients
Part of Brain & nervous system clinical trials.
This study tests a new medicine called SIF001 for safety. It first gives the medicine to healthy volunteers, and then to people with epilepsy who have seizures even while on their current medicines. The goal is to find a safe dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can be a healthy adult 18 to 55 years old, or an adult with epilepsy 18 to 70 years old.
- If you have epilepsy, you must have at least 4 motor seizures (like convulsions) every 4 weeks, even while taking 1 to 3 seizure medicines.
- Your seizure medicines must have been the same for at least 8 weeks before the study starts.
- You must be in good overall health, with no serious medical conditions, and have normal liver, kidney, and heart function.
- You must agree to use effective birth control if you are of childbearing age.
- You cannot have had a seizure emergency (status epilepticus) in the last 2 years, or have recent suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called S-4321 to make sure it's safe and well-tolerated in healthy people. You would take the drug and have regular check-ups to see how your body handles it.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
This trial tests a new experimental drug (ISM4808) in healthy adults to see how safe it is and how the body handles it. It may help researchers learn if the drug is promising for future treatments.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.